...
ctkb-img

Cytek Biosciences Inc, Common Stock

CTKB

NSQ

$6.47

-$0.07

(-1.07%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$861.75M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
430.31K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.32
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.66 L
$9.87 H
$6.47

About Cytek Biosciences Inc, Common Stock

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameCTKBSectorS&P500
1-Week Return-0.92%-2.12%0.77%
1-Month Return-12.57%-2.54%2.65%
3-Month Return22.08%-6.28%12.3%
6-Month Return8.38%-1.36%13.48%
1-Year Return-11.61%9.29%33.47%
3-Year Return-65.82%10.05%32.22%
5-Year Return-65.51%43.69%92.85%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue57.88M92.84M127.95M164.04M193.01M[{"date":"2019-12-31","value":29.99,"profit":true},{"date":"2020-12-31","value":48.1,"profit":true},{"date":"2021-12-31","value":66.29,"profit":true},{"date":"2022-12-31","value":84.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue29.21M41.13M48.81M63.06M83.59M[{"date":"2019-12-31","value":34.94,"profit":true},{"date":"2020-12-31","value":49.2,"profit":true},{"date":"2021-12-31","value":58.39,"profit":true},{"date":"2022-12-31","value":75.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit28.67M51.71M79.14M100.97M109.43M[{"date":"2019-12-31","value":26.2,"profit":true},{"date":"2020-12-31","value":47.26,"profit":true},{"date":"2021-12-31","value":72.33,"profit":true},{"date":"2022-12-31","value":92.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin49.54%55.70%61.86%61.56%56.69%[{"date":"2019-12-31","value":80.09,"profit":true},{"date":"2020-12-31","value":90.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.52,"profit":true},{"date":"2023-12-31","value":91.65,"profit":true}]
Operating Expenses25.91M38.05M69.98M102.78M137.27M[{"date":"2019-12-31","value":18.88,"profit":true},{"date":"2020-12-31","value":27.72,"profit":true},{"date":"2021-12-31","value":50.98,"profit":true},{"date":"2022-12-31","value":74.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income3.73M13.66M6.45M(1.83M)(27.84M)[{"date":"2019-12-31","value":27.28,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":47.2,"profit":true},{"date":"2022-12-31","value":-13.37,"profit":false},{"date":"2023-12-31","value":-203.86,"profit":false}]
Total Non-Operating Income/Expense(19.31M)548.00K(4.91M)5.11M17.36M[{"date":"2019-12-31","value":-111.21,"profit":false},{"date":"2020-12-31","value":3.16,"profit":true},{"date":"2021-12-31","value":-28.28,"profit":false},{"date":"2022-12-31","value":29.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(16.29M)14.43M5.95M1.26M(15.71M)[{"date":"2019-12-31","value":-112.92,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.22,"profit":true},{"date":"2022-12-31","value":8.73,"profit":true},{"date":"2023-12-31","value":-108.86,"profit":false}]
Income Taxes533.00K(4.98M)1.50M(1.22M)(3.56M)[{"date":"2019-12-31","value":35.42,"profit":true},{"date":"2020-12-31","value":-330.96,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-81.33,"profit":false},{"date":"2023-12-31","value":-236.61,"profit":false}]
Income After Taxes(16.83M)19.41M4.44M2.48M(12.15M)[{"date":"2019-12-31","value":-86.69,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":22.89,"profit":true},{"date":"2022-12-31","value":12.8,"profit":true},{"date":"2023-12-31","value":-62.58,"profit":false}]
Income From Continuous Operations(16.83M)19.41M4.44M2.48M(13.93M)[{"date":"2019-12-31","value":-86.69,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":22.89,"profit":true},{"date":"2022-12-31","value":12.8,"profit":true},{"date":"2023-12-31","value":-71.78,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(16.83M)19.41M4.42M2.58M(12.15M)[{"date":"2019-12-31","value":-86.69,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":22.76,"profit":true},{"date":"2022-12-31","value":13.27,"profit":true},{"date":"2023-12-31","value":-62.58,"profit":false}]
EPS (Diluted)(0.03)-0.120.14(0.09)[{"date":"2019-12-31","value":-21.43,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":85.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-64.29,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CTKB
Cash Ratio 4.42
Current Ratio 6.21
Quick Ratio 5.47

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CTKB
ROA (LTM) -2.74%
ROE (LTM) -2.54%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CTKB
Debt Ratio Lower is generally better. Negative is bad. 0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.78

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CTKB
Trailing PE NM
Forward PE 370.37
P/S (TTM) 4.14
P/B 2.16
Price/FCF 67
EV/R 2.83
EV/Ebitda NM

FAQs

What is Cytek Biosciences Inc share price today?

Cytek Biosciences Inc (CTKB) share price today is $6.47

Can Indians buy Cytek Biosciences Inc shares?

Yes, Indians can buy shares of Cytek Biosciences Inc (CTKB) on Vested. To buy Cytek Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CTKB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cytek Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Cytek Biosciences Inc (CTKB) via the Vested app. You can start investing in Cytek Biosciences Inc (CTKB) with a minimum investment of $1.

How to invest in Cytek Biosciences Inc shares from India?

You can invest in shares of Cytek Biosciences Inc (CTKB) via Vested in three simple steps:

  • Click on Sign Up or Invest in CTKB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cytek Biosciences Inc shares
What is Cytek Biosciences Inc 52-week high and low stock price?

The 52-week high price of Cytek Biosciences Inc (CTKB) is $9.87. The 52-week low price of Cytek Biosciences Inc (CTKB) is $4.66.

What is Cytek Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cytek Biosciences Inc (CTKB) is

What is Cytek Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cytek Biosciences Inc (CTKB) is 2.16

What is Cytek Biosciences Inc dividend yield?

The dividend yield of Cytek Biosciences Inc (CTKB) is 0.00%

What is the Market Cap of Cytek Biosciences Inc?

The market capitalization of Cytek Biosciences Inc (CTKB) is $861.75M

What is Cytek Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Cytek Biosciences Inc is CTKB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top